These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8156000)

  • 1. Degranulation from human eosinophils stimulated with C3a and C5a.
    Takafuji S; Tadokoro K; Ito K; Dahinden CA
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):27-9. PubMed ID: 8156000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
    Takafuji S; Tadokoro K; Ito K
    Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
    Egesten A; Malm J
    Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations.
    Zeck-Kapp G; Kroegel C; Riede UN; Kapp A
    Allergy; 1995 Jan; 50(1):34-47. PubMed ID: 7741187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil degranulation in the presence of lung fibroblasts.
    Takafuji S; Shoji S; Ito K; Yamamoto K; Nakagawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():52-4. PubMed ID: 9758898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion.
    Jagels MA; Daffern PJ; Hugli TE
    Immunopharmacology; 2000 Mar; 46(3):209-22. PubMed ID: 10741901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of human lung fibroblasts on eosinophil degranulation.
    Takafuji S; Miyakuni Y; Nakagawa T; Shoji S; Murata S; Yamamoto K; Ito K
    Allergy; 2000 Dec; 55(12):1170-8. PubMed ID: 11117275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
    Xu X; Håkansson L
    Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
    Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
    J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils.
    Elsner J; Oppermann M; Czech W; Dobos G; Schöpf E; Norgauer J; Kapp A
    Eur J Immunol; 1994 Mar; 24(3):518-22. PubMed ID: 8125125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils.
    Takafuji S; Tadokoro K; Ito K; Dahinden CA
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():36-8. PubMed ID: 7549519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.
    Daffern PJ; Pfeifer PH; Ember JA; Hugli TE
    J Exp Med; 1995 Jun; 181(6):2119-27. PubMed ID: 7760001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.
    Agrawal DK; Takami M; Ono S
    Inflammation; 1997 Feb; 21(1):1-8. PubMed ID: 9179617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha.
    Egesten A; Blom M; Calafat J; Janssen H; Knol EF
    Int Arch Allergy Immunol; 1998 Feb; 115(2):121-8. PubMed ID: 9482700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
    Takafuji S; Tadokoro K; Ito K; Nakagawa T
    Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.
    West PW; Bahri R; Garcia-Rodriguez KM; Sweetland G; Wileman G; Shah R; Montero A; Rapley L; Bulfone-Paus S
    Front Immunol; 2020; 11():615236. PubMed ID: 33597949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins.
    Egesten A; Gullberg U; Olsson I; Richter J
    J Leukoc Biol; 1993 Mar; 53(3):287-93. PubMed ID: 8095965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion.
    Takafuji S; Ohtoshi T; Takizawa H; Tadokoro K; Ito K
    J Immunol; 1996 May; 156(10):3980-5. PubMed ID: 8621939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
    Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
    J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
    Winqvist I; Olofsson T; Olsson I
    Immunology; 1984 Jan; 51(1):1-8. PubMed ID: 6317543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.